1
|
Jésus P, Fayemendy P, Marin B, Lautrette G, Labrunie A, Preux PM, Luna J, Desport JC, Couratier P. Impact sur l’état fonctionnel d’une complémentation nutritionnelle oral (CNO) précoce des patients atteints de sclérose latérale amyotrophie (SLA) : étude nationale multicentrique NUTRALS. NUTR CLIN METAB 2022. [DOI: 10.1016/j.nupar.2021.12.037] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
2
|
Couratier P, Lautrette G, Luna JA, Corcia P. Phenotypic variability in amyotrophic lateral sclerosis. Rev Neurol (Paris) 2021; 177:536-543. [PMID: 33902945 DOI: 10.1016/j.neurol.2021.03.001] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/22/2021] [Revised: 03/14/2021] [Accepted: 03/16/2021] [Indexed: 10/21/2022]
Abstract
Clinically, ALS phenotypes depend on the areas of the body that are affected, the different degrees of involvement of upper and lower motor neurons, the degrees of involvement of other systems, particularly cognition and behavior, and rates of progression. Phenotypic variability of ALS is characteristic and can be declined on the distribution of motor manifestations but also on the presence of extra-motor signs present in a variable manner in ALS patients. Neuropathologically, ALS is defined by the loss of UMN and LMN and the presence of two representative motor neuronal cytoplasmic inclusions, Bunina bodies and 43kDa Transactivation Response DNA Binding Protein (TDP-43) - positive cytoplasmic inclusions. The distribution of cytopathology and neuronal loss in patients is variable and this variability is directly related to phenotypic variability. Key regulators of phenotypic variability in ALS have not been determined. The functional decrement of TDP-43, and region-specific neuronal susceptibility to ALS, may be involved. Due to the selective vulnerability among different neuronal systems, lesions are multicentric, region-oriented, and progress at different rates. They may vary from patient to patient, which may be linked to the clinicopathological variability across patients.
Collapse
Affiliation(s)
- P Couratier
- Service de neurologie, centre de référence maladies rares SLA et autres maladies du neurone moteur, CHU de Limoges, Limoges, France; Inserm, IRD, U1094 Tropical Neuroepidemiology, Institute of Epidemiology and Tropical Neurology, GEIST, université de Limoges, CHU de Limoges, Limoges, France; Fédération des Centres SLA de Limoges et Tours, Litorals, Limoges, France.
| | - G Lautrette
- Service de neurologie, centre de référence maladies rares SLA et autres maladies du neurone moteur, CHU de Limoges, Limoges, France; Fédération des Centres SLA de Limoges et Tours, Litorals, Limoges, France
| | - J A Luna
- Inserm, IRD, U1094 Tropical Neuroepidemiology, Institute of Epidemiology and Tropical Neurology, GEIST, université de Limoges, CHU de Limoges, Limoges, France
| | - P Corcia
- Fédération des Centres SLA de Limoges et Tours, Litorals, Limoges, France; Centre de référence maladies rares SLA et autres maladies du neurone moteur, CHU Bretonneau, Tours, France
| |
Collapse
|
3
|
Fayemendy P, Calmel N, Sourisseau H, Lautrette G, Preux PM, Couratier P, Desport J, Jésus P. Survie selon la variation de la dépense énergétique au repos (DER) avec deux formules de DER en l’absence de calorimétrie indirecte chez les patients atteints de sclérose latérale amyotrophique. NUTR CLIN METAB 2021. [DOI: 10.1016/j.nupar.2021.01.068] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
4
|
Fayemendy P, Calmel N, Sourisseau H, Lautrette G, Preux PM, Couratier P, Desport J, Jésus P. Étude du seuil le plus pertinent de variation de la dépense énergétique au repos pour dépister les patients atteints de sclérose latérale amyotrophique à plus haut risque évolutif. NUTR CLIN METAB 2021. [DOI: 10.1016/j.nupar.2021.01.060] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
5
|
Fayemendy P, Calmel N, Sourisseau H, Lautrette G, Preux PM, Couratier P, Desport J, Jésus P. État nutritionnel et métabolique au diagnostic et survie des patients atteints de sclérose latérale amyotrophique (SLA) avec démence frontotemporale versus patients atteints de SLA seule. NUTR CLIN METAB 2021. [DOI: 10.1016/j.nupar.2021.01.059] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
6
|
Nasser Y, Fayemendy P, Calmel N, Sourisseau H, Lautrette G, Preux PM, Couratier P, Desport J, Jésus P. Impact de la prise en charge par un réseau nutritionnel de santé à domicile sur l’évolution des patients atteints de sclérose latérale amyotrophique. NUTR CLIN METAB 2021. [DOI: 10.1016/j.nupar.2021.01.061] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
7
|
Jésus P, Fayemendy P, Calmel N, Sourisseau H, Lautrette G, Preux P, Couratier P, Desport J. Survival according to resting energy expenditure (REE) variation using two ree formulas and without indirect calorimetry in patients with amyotrophic lateral sclerosis (ALS). Clin Nutr ESPEN 2020. [DOI: 10.1016/j.clnesp.2020.09.238] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
8
|
Jésus P, Fayemendy P, Sourisseau H, Lautrette G, Preux P, Couratier P, Desport J. Study of the relevant threshold of resting energy expenditure variation to screen at diagnosis patients with amyotrophic lateral sclerosis with the higher evolving risk. Clin Nutr ESPEN 2020. [DOI: 10.1016/j.clnesp.2020.09.236] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
9
|
Jésus P, Fayemendy P, Calmel N, Sourisseau H, Lautrette G, Preux P, Couratier P, Desport J. Nutritional and metabolic status at diagnosis and survival of patients with amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) compared to patients with ALS alone. Clin Nutr ESPEN 2020. [DOI: 10.1016/j.clnesp.2020.09.110] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
10
|
Fayemendy P, Vergonjeanne M, Lautrette G, Calmel N, Sourisseau H, Preux P, Couratier P, Desport J, Jésus P. Follow-up and survival after gastrostomy indication in patients with amyotrophic lateral sclerosis. Clin Nutr ESPEN 2020. [DOI: 10.1016/j.clnesp.2020.09.393] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
11
|
Vergonjeanne M, Fayemendy P, Marin B, Nicol M, Lautrette G, Sourisseau H, Preux P, Desport J, Couratier P, Jésus P. Impact de la gastrostomie sur la survie des patients atteints de la sclérose latérale amyotrophique (sla), en fonction de leur perte ponderale au cours du temps. NUTR CLIN METAB 2019. [DOI: 10.1016/j.nupar.2019.01.248] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
12
|
Corcia P, Beltran S, Lautrette G, Bakkouche S, Couratier P. Staging amyotrophic lateral sclerosis: A new focus on progression. Rev Neurol (Paris) 2018; 175:277-282. [PMID: 30606512 DOI: 10.1016/j.neurol.2018.09.017] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/28/2018] [Revised: 09/04/2018] [Accepted: 09/07/2018] [Indexed: 12/11/2022]
Abstract
Amyotrophic lateral sclerosis (ALS) is a heterogenous motoneuronal neurodegenerative condition with a panel of phenotypes exhibiting different clinical patterns. Two compounds are currently available for the treatment of ALS but the majority of trials have failed to show a positive effect on prognosis. One of the explanations which could be put forward involves the way efficacy is evaluated: clinicians agree that the ALSFRS-revised scale used in all trials does not fit with highlighting a positive effect. So, the development and validation of new tools allowing a reliable assessment of ALS has become a key issue in clinical research. Over the last three years, two functional scales (the King's College and MiToS staging systems) have been proposed. These scales rely on two different approaches to ALS: an anatomical and prognostic concept, and loss of autonomy. Both scales propose five stages. We will discuss below the contribution of these two scales to clinical evaluation and the questions which remain to be resolved in the future.
Collapse
Affiliation(s)
- P Corcia
- Centre Constitutif SLA, CHU Tours, 2, boulevard Tonnellé, 37044 Tours cedex 1, France; Fédération des centres SLA de Tours et Limoges, Litorals, France.
| | - S Beltran
- Centre Constitutif SLA, CHU Tours, 2, boulevard Tonnellé, 37044 Tours cedex 1, France; Fédération des centres SLA de Tours et Limoges, Litorals, France
| | - G Lautrette
- Centre Constitutif SLA, CHU Tours, 2, boulevard Tonnellé, 37044 Tours cedex 1, France; Centre de coordination de la filière FILSLAN, CHU Limoges, France
| | - S Bakkouche
- Centre Constitutif SLA, CHU Tours, 2, boulevard Tonnellé, 37044 Tours cedex 1, France
| | - P Couratier
- Fédération des centres SLA de Tours et Limoges, Litorals, France; Centre de coordination de la filière FILSLAN, CHU Limoges, France
| |
Collapse
|
13
|
Fayemendy P, Marin B, Nicol M, Labrunie A, Sourisseau H, Boirie Y, Walrand S, Achamrah N, Coëffier M, Preux P, Lautrette G, Couratier P, Desport J, Jésus P. Confirmation of hypermetabolism in amyotrophic lateral sclerosis patients: A study versus healthy control. Clin Nutr 2018. [DOI: 10.1016/j.clnu.2018.06.1105] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
14
|
Jésus P, Marin B, Fayemendy P, Nicol M, Lautrette G, Sourisseau H, Preux P, Couratier P, Desport J. Resting energy expenditure equations in amyotrophic lateral sclerosis, creation of an ALS-specific equation. Clin Nutr 2018. [DOI: 10.1016/j.clnu.2018.06.2100] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
15
|
Aslanbekova N, Lautrette G, Ratti N, Liozon E, Fauchais A, Ly K. Association sarcoïdose et sclérose latérale amyotrophique : un diagnostic rare et difficile. Rev Med Interne 2018. [DOI: 10.1016/j.revmed.2018.03.244] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
16
|
Jésus P, Fayemendy P, Nicol M, Lautrette G, Sourisseau H, Preux PM, Desport JC, Marin B, Couratier P. Hypermetabolism is a deleterious prognostic factor in patients with amyotrophic lateral sclerosis. Eur J Neurol 2017; 25:97-104. [PMID: 28940704 DOI: 10.1111/ene.13468] [Citation(s) in RCA: 65] [Impact Index Per Article: 9.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/14/2017] [Accepted: 09/04/2017] [Indexed: 12/30/2022]
Abstract
BACKGROUND AND PURPOSE The aim of this study was to investigate patients with amyotrophic lateral sclerosis in order to determine their nutritional, neurological and respiratory parameters, and survival according to metabolic level. METHODS Nutritional assessment included resting energy expenditure (REE) measured by indirect calorimetry [hypermetabolism if REE variation (ΔREE) > 10%] and fat mass (FM) using impedancemetry. Neurological assessment included the Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised score. Survival analysis used the Kaplan-Meier method and multivariate Cox model. RESULTS A total of 315 patients were analysed. Median age at diagnosis was 65.9 years and 55.2% of patients were hypermetabolic. With regard to the metabolic level (ΔREE: < 10%, 10-20% and >20%), patients with ΔREE > 20% initially had a lower FM(29.7% vs. 32.1% in those with ΔREE ≤10%; P = 0.0054). During follow-up, the median slope of Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised tended to worsen more in patients with ΔREE > 20% (-1.4 vs. -1.0 points/month in those with ΔREE ≤10%; P = 0.07). Overall median survival since diagnosis was 18.4 months. ΔREE > 20% tended to increase the risk of dying compared with ΔREE ≤10% (hazard ratio, 1.33; P = 0.055). In multivariate analysis, an increased REE:FM ratio was independently associated with death (hazard ratio, 1.005; P = 0.001). CONCLUSIONS Hypermetabolism is present in more than half of patients with amyotrophic lateral sclerosis. It modifies the body composition at diagnosis, and patients with hypermetabolism >20% have a worse prognosis than those without hypermetabolism.
Collapse
Affiliation(s)
- P Jésus
- Nutrition Unit, University Hospital of Limoges, Limoges.,INSERM, U1094, Tropical Neuroepidemiology, Limoges
| | - P Fayemendy
- Nutrition Unit, University Hospital of Limoges, Limoges.,INSERM, U1094, Tropical Neuroepidemiology, Limoges
| | - M Nicol
- INSERM, U1094, Tropical Neuroepidemiology, Limoges.,ALS Center, University Hospital of Limoges, Limoges
| | - G Lautrette
- ALS Center, University Hospital of Limoges, Limoges
| | - H Sourisseau
- Nutrition Unit, University Hospital of Limoges, Limoges
| | - P-M Preux
- INSERM, U1094, Tropical Neuroepidemiology, Limoges.,Center of Epidemiology, Biostatistics and Research Methodology, University Hospital of Limoges, Limoges, France
| | - J-C Desport
- Nutrition Unit, University Hospital of Limoges, Limoges.,INSERM, U1094, Tropical Neuroepidemiology, Limoges
| | - B Marin
- INSERM, U1094, Tropical Neuroepidemiology, Limoges.,Center of Epidemiology, Biostatistics and Research Methodology, University Hospital of Limoges, Limoges, France
| | - P Couratier
- INSERM, U1094, Tropical Neuroepidemiology, Limoges.,ALS Center, University Hospital of Limoges, Limoges
| |
Collapse
|
17
|
Jésus P, Marin B, Fayemendy P, Nicol M, Lautrette G, Sourisseau H, Preux PM, Couratier P, Desport JC. Survie, statut évolutif et facteurs associés à l’hypermétabolisme au cours de la sclérose latérale amyotrophique. NUTR CLIN METAB 2017. [DOI: 10.1016/j.nupar.2017.06.067] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
18
|
Courseau M, Bonnet C, Lautrette G, Gondran G, Fauchais A, Ly K. Sarcoïdose osseuse de forme disséminée pauci-symptomatique : à propos de 2 cas. Rev Med Interne 2017. [DOI: 10.1016/j.revmed.2017.03.271] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
19
|
Couratier P, Corcia P, Lautrette G, Nicol M, Marin B. ALS and frontotemporal dementia belong to a common disease spectrum. Rev Neurol (Paris) 2017; 173:273-279. [DOI: 10.1016/j.neurol.2017.04.001] [Citation(s) in RCA: 40] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/04/2017] [Accepted: 04/05/2017] [Indexed: 12/13/2022]
|
20
|
Marin B, Beghi E, Vial C, Bernard E, Lautrette G, Clavelou P, Guy N, Lemasson G, Debruxelles S, Cintas P, Antoine JC, Camdessanche JP, Logroscino G, Preux PM, Couratier P. Evaluation of the application of the European guidelines for the diagnosis and clinical care of amyotrophic lateral sclerosis (ALS) patients in six French ALS centres. Eur J Neurol 2016; 23:787-95. [DOI: 10.1111/ene.12941] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/03/2015] [Accepted: 11/13/2015] [Indexed: 11/28/2022]
Affiliation(s)
- B. Marin
- INSERM, U1094; Tropical Neuroepidemiology; Limoges France
- Univ. Limoges; UMR_S 1094; Tropical Neuroepidemiology; Institute of Neuroepidemiology and Tropical Neurology; CNRS FR 3503 GEIST; F-87000 Limoges France
- CHU Limoges; Centre d'Epidémiologie de Biostatistique et de Méthodologie de la Recherche; Limoges France
| | - E. Beghi
- Laboratorio di Malattie Neurologiche; Dipartimento di Neuroscienze; IRCCS Istituto di Ricerche Farmacologiche Mario Negri; Milano Italy
| | - C. Vial
- CHU Lyon Hôpital Neurologique P. Wertheimer; Electromyographie et pathologies neuromusculaires; Lyon France
| | - E. Bernard
- CHU Lyon Hôpital Neurologique P. Wertheimer; Electromyographie et pathologies neuromusculaires; Lyon France
| | - G. Lautrette
- CHU Limoges; Service de Neurologie; Centre Expert SLA; Limoges France
| | - P. Clavelou
- CHU Clermont-Ferrand; Hopital Gabriel Montpied; Service de Neurologie; Centre Expert SLA; Clermont-Ferrand France
| | - N. Guy
- CHU Clermont-Ferrand; Hopital Gabriel Montpied; Service de Neurologie; Centre Expert SLA; Clermont-Ferrand France
| | - G. Lemasson
- CHU Pellegrin; Service de Neurologie; Centre Expert SLA; Bordeaux France
| | - S. Debruxelles
- CHU Pellegrin; Service de Neurologie; Centre Expert SLA; Bordeaux France
| | - P. Cintas
- CHU Toulouse Purpan; Centre Expert SLA; Unité de neurophysiologie clinique; Toulouse France
| | - J. C. Antoine
- CHU Saint-Étienne; Hôpital Nord; Service de Neurologie; Centre Expert SLA; Saint-Étienne France
| | - J. P. Camdessanche
- CHU Saint-Étienne; Hôpital Nord; Service de Neurologie; Centre Expert SLA; Saint-Étienne France
| | - G. Logroscino
- Department of Basic Medical Sciences; Neuroscience and Sense Organs; University of Bari ‘Aldo Moro’; Bari Italy
- Unit of Neurodegenerative Diseases; Department of Clinical Research in Neurology; University of Bari ‘Aldo Moro’; at Pia Fondazione Cardinale G. Panico; Tricase Lecce Italy
| | - P. M. Preux
- INSERM, U1094; Tropical Neuroepidemiology; Limoges France
- Univ. Limoges; UMR_S 1094; Tropical Neuroepidemiology; Institute of Neuroepidemiology and Tropical Neurology; CNRS FR 3503 GEIST; F-87000 Limoges France
- CHU Limoges; Centre d'Epidémiologie de Biostatistique et de Méthodologie de la Recherche; Limoges France
| | - P. Couratier
- INSERM, U1094; Tropical Neuroepidemiology; Limoges France
- Univ. Limoges; UMR_S 1094; Tropical Neuroepidemiology; Institute of Neuroepidemiology and Tropical Neurology; CNRS FR 3503 GEIST; F-87000 Limoges France
- CHU Limoges; Service de Neurologie; Centre Expert SLA; Limoges France
| | | |
Collapse
|
21
|
Couratier P, Corcia P, Lautrette G, Nicol M, Preux PM, Marin B. Epidemiology of amyotrophic lateral sclerosis: A review of literature. Rev Neurol (Paris) 2015; 172:37-45. [PMID: 26727307 DOI: 10.1016/j.neurol.2015.11.002] [Citation(s) in RCA: 76] [Impact Index Per Article: 8.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/03/2015] [Accepted: 11/10/2015] [Indexed: 12/11/2022]
Abstract
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease of motor neurons, resulting in worsening weakness of voluntary muscles until death occurs from respiratory failure. The incidence of ALS in European populations is two to three people per year per 100,000 of the general population. In Europe, crude prevalences range from 1.1/100,000 population in Yugoslavia to 8.2/100,000 in the Faroe Islands. Major advances have been made in our understanding of the genetic causes of ALS, whereas the contribution of environmental factors has been more difficult to assess and large-scale studies have not yet revealed a replicable, definitive environmental risk factor. The only established risk factors to date are older age, male gender and a family history of ALS. Median survival time from onset to death is usually 3 years from the first appearance of symptoms. Older age and bulbar onset are consistently reported to have poorer outcomes. However, there are conflicting data regarding gender, diagnostic delay and El Escorial criteria. The rate of symptom progression has been revealed to be an independent prognostic factor. Psychosocial factors and impaired cognitive function are negatively related to ALS outcome, while nutritional status and respiratory function are also related to ALS prognosis. The effect of enteral nutrition on survival is still unclear, although noninvasive positive pressure ventilation (NIPPV) has been found to improve survival. These findings have relevant implications for the design of future trials.
Collapse
Affiliation(s)
- P Couratier
- Centre de compétence SLA-fédération Tours-Limoges, CHU de Limoges, 2, avenue Martin-Luther-King, 87000 Limoges, France; Inserm UMR1094, neuroépidémiologie tropicale, université de Limoges, 2, rue du Dr.-Marcland, 87025 Limoges cedex, France.
| | - P Corcia
- Centre de compétence SLA-fédération Tours-Limoges, CHU de Tours, 37044 Tours cedex 9, France
| | - G Lautrette
- Centre de compétence SLA-fédération Tours-Limoges, CHU de Limoges, 2, avenue Martin-Luther-King, 87000 Limoges, France
| | - M Nicol
- Centre de compétence SLA-fédération Tours-Limoges, CHU de Limoges, 2, avenue Martin-Luther-King, 87000 Limoges, France
| | - P-M Preux
- Inserm UMR1094, neuroépidémiologie tropicale, université de Limoges, 2, rue du Dr.-Marcland, 87025 Limoges cedex, France
| | - B Marin
- Inserm UMR1094, neuroépidémiologie tropicale, université de Limoges, 2, rue du Dr.-Marcland, 87025 Limoges cedex, France
| |
Collapse
|
22
|
Marin B, Hamidou B, Couratier P, Nicol M, Delzor A, Raymondeau M, Druet-Cabanac M, Lautrette G, Boumediene F, Preux PM. Population-based epidemiology of amyotrophic lateral sclerosis (ALS) in an ageing Europe--the French register of ALS in Limousin (FRALim register). Eur J Neurol 2014; 21:1292-300, e78-9. [PMID: 24909935 DOI: 10.1111/ene.12474] [Citation(s) in RCA: 46] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/31/2014] [Accepted: 04/22/2014] [Indexed: 11/27/2022]
Abstract
BACKGROUND AND PURPOSE The main objective of establishing the French register of amyotrophic lateral sclerosis (ALS) in the Limousin region (FRALim), was to assess the incidence of ALS, in this ageing region of Europe, over a 12-year period (2000-2011). METHODS Patients were included if they lived in Limousin at the time of diagnosis of ALS according to El Escorial revised criteria and were identified by at least one of the following sources: (i) the French national body coordinating ALS referral centres; (ii) public and private hospitals in the region; (iii) health insurance data related to long-term diseases. RESULTS The FRALim register identified 279 incident cases (2000-2011). The crude and European population standardized incidences of ALS were as high as 3.19/100,000 person-years of follow-up (95% CI 2.81-3.56) and 2.58/100,000 person-years of follow-up (95% CI 2.27-2.89) respectively. Median age at onset was 70.8 years (interquartile range 63.1-77.1). The standardized sex incidence ratio (male/female) was 1.3 overall, but 1.1 under the age of 65 years, 1.7 between 65 and 75 years and 1.9 above 75 years. The exhaustiveness of the register has been estimated at 98.4% (95% CI 95.6-99.4) by capture-recapture analysis. CONCLUSION It was possible for the first time in France to monitor accurately the incidence of ALS over a long time period. It appears to be in the upper range of data reported in western countries. Patterns displayed here might anticipate the epidemiology of ALS in ageing western countries.
Collapse
Affiliation(s)
- B Marin
- INSERM UMR1094, Tropical Neuroepidemiology, Limoges, France; Université de Limoges, School of Medicine, Institute of Neuroepidemiology and Tropical Neurology, CNRS FR 3503 GEIST, Limoges, France; CHU Limoges, Unité Fonctionnelle de Recherche Clinique et de Biostatistique, Limoges, France
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
23
|
Marin B, Hamidou B, Couratier P, Lautrette G, Nicol M, Preux PM. Sclérose latérale amyotrophique et activité physique et sportive. Rev Neurol (Paris) 2013. [DOI: 10.1016/j.neurol.2013.01.447] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
24
|
Archambeaud F, Lautrette G, Galinat S. Syndrome de Gougerot-Sjögren et orbitopathie basedowienne. Rev Med Interne 2006. [DOI: 10.1016/j.revmed.2006.10.133] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|